All Articles

BioCardia bets its future on Japan's fast-track approval for its heart therapy, a strategic pivot that could unlock global markets or break the bank.

Perion's new 'Ask Perion' AI aims to automate ad campaigns. But does this self-serve model truly empower marketers or just boost Perion's bottom line?

Industrial arm maker INLIF is jumping into the humanoid race. But can a small firm with unverified claims compete with giants like Boston Dynamics and Tesla?

A new grant from The Michael J. Fox Foundation highlights a radical approach to Parkinson's: targeting astrocytes to restore balance and halt neurodegeneration.

A new drug from Cambrian Bio shows promise in activating a key metabolic switch. This could lead to treatments that burn fat while preserving muscle mass.

A new app from a Siri co-founder is embedding intelligent AR characters into our messages. But is this the future of connection or just a novel distraction?

An executive award for Valley Bank's Russell Barrett pulls back the curtain on a deeper strategy: a disciplined, multi-year overhaul of the bank's tech core.

A PR firm launches a daily financial newsletter for the lower middle market, betting that speed and focus can win over dealmakers in a crowded, vital field.

A 200-year-old bank is partnering with Flare AI, ditching software licenses for guaranteed outcomes. This move could redefine how regulated industries adopt tech.

A massive $600M financing deal for a solar and battery project in California signals a new era of strategic investment in renewable infrastructure.

Seven years ago, 'Global Warning' was dismissed as a niche documentary. Today, its director claims it's the key to Canada's future. What changed?

E-commerce brands are drowning in fragmented data. A new partnership between Shirofune and Triple Whale offers a single source of truth to automate ad optimization.

A new survey reveals half of Americans feel a summer cash crunch, but for Gen Z, it's a crisis forcing drastic measures, from 60-hour weeks to new digital frontiers.

A new firm, Nortiva Bio, is launching with tech from MIT to turn daily pills into monthly doses, starting with a contraceptive backed by the Gates Foundation.

Verdantas' latest acquisition of New Jersey-based Yu & Associates signals a major push to dominate the Northeast's engineering and environmental market.

Eason Technology leadership's big share purchase signals confidence. But with declining revenue and a "going concern" warning, is this a bet on a real turnaround?

Travel is more accessible than ever, yet 93% of travelers say logistics ruin their trips. A new report reveals the hidden cost of our hyper-connected world.

How do you upgrade a factory that never sleeps? Chery and ForwardX have an answer, deploying 484 robots in a live plant, setting a new industry standard.

Following its massive Synovus merger, Pinnacle is planting its corporate flag in Atlanta, signaling a bold challenge to the city's banking titans.

Goldfish Swim School's new 'Dads & Minis' program is more than a swim class; it's a strategic move to engage fathers, combat drowning stats, and innovate.